Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Genetic analysis of intestinal polyp development in Collaborative Cross mice carrying the Apc (Min/+) mutation.

Dorman A, Baer D, Tomlinson I, Mott R, Iraqi FA.

BMC Genet. 2016 Feb 19;17:46. doi: 10.1186/s12863-016-0349-6. Erratum in: BMC Genet. 2016 Nov 24;17 (1):147.

2.

Identification of five novel modifier loci of Apc(Min) harbored in the BXH14 recombinant inbred strain.

Nnadi SC, Watson R, Innocent J, Gonye GE, Buchberg AM, Siracusa LD.

Carcinogenesis. 2012 Aug;33(8):1589-97. doi: 10.1093/carcin/bgs185. Epub 2012 May 24.

3.

Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia.

Silverman KA, Koratkar R, Siracusa LD, Buchberg AM.

Genome Res. 2002 Jan;12(1):88-97.

4.

Reduction in alkaline sphingomyelinase in colorectal tumorigenesis is not related to the APC gene mutation.

Hertervig E, Nilsson A, Nilbert M, Duan RD.

Int J Colorectal Dis. 2003 Jul;18(4):309-13. Epub 2003 Mar 4.

PMID:
12774245
5.

Identification of Mom12 and Mom13, two novel modifier loci of Apc (Min) -mediated intestinal tumorigenesis.

Crist RC, Roth JJ, Lisanti MP, Siracusa LD, Buchberg AM.

Cell Cycle. 2011 Apr 1;10(7):1092-9. Epub 2011 Apr 1.

6.

Understanding phenotypic variation in rodent models with germline Apc mutations.

Zeineldin M, Neufeld KL.

Cancer Res. 2013 Apr 15;73(8):2389-99. doi: 10.1158/0008-5472.CAN-12-4607. Epub 2013 Apr 11. Review.

7.

Analysis of reciprocal congenic lines reveals the C3H/HeJ genome to be highly resistant to ApcMin intestinal tumorigenesis.

Koratkar R, Silverman KA, Pequignot E, Hauck WW, Buchberg AM, Siracusa LD.

Genomics. 2004 Nov;84(5):844-52.

PMID:
15475263
8.
9.

Genetic dissection of the Mom5 modifier locus and evaluation of Mom5 candidate genes.

Otterpohl KL, Gould KA.

Mamm Genome. 2015 Jun;26(5-6):235-47. doi: 10.1007/s00335-015-9567-x. Epub 2015 May 15.

PMID:
25976411
10.

Somatic mutations of the adenomatous polyposis coli gene in gastroduodenal tumors from patients with familial adenomatous polyposis.

Toyooka M, Konishi M, Kikuchi-Yanoshita R, Iwama T, Miyaki M.

Cancer Res. 1995 Jul 15;55(14):3165-70.

11.

The armadillo repeat domain of Apc suppresses intestinal tumorigenesis.

Crist RC, Roth JJ, Baran AA, McEntee BJ, Siracusa LD, Buchberg AM.

Mamm Genome. 2010 Oct;21(9-10):450-7. doi: 10.1007/s00335-010-9288-0. Epub 2010 Oct 1.

12.
13.
14.

Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice.

Yamada Y, Hata K, Hirose Y, Hara A, Sugie S, Kuno T, Yoshimi N, Tanaka T, Mori H.

Cancer Res. 2002 Nov 15;62(22):6367-70.

15.

APC in the regulation of intestinal crypt fission.

Wasan HS, Park HS, Liu KC, Mandir NK, Winnett A, Sasieni P, Bodmer WF, Goodlad RA, Wright NA.

J Pathol. 1998 Jul;185(3):246-55.

PMID:
9771477
16.

Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis.

Groves C, Lamlum H, Crabtree M, Williamson J, Taylor C, Bass S, Cuthbert-Heavens D, Hodgson S, Phillips R, Tomlinson I.

Am J Pathol. 2002 Jun;160(6):2055-61.

17.

A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis.

Gaspar C, Franken P, Molenaar L, Breukel C, van der Valk M, Smits R, Fodde R.

PLoS Genet. 2009 Jul;5(7):e1000547. doi: 10.1371/journal.pgen.1000547. Epub 2009 Jul 3.

18.

Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.

Yekkala K, Baudino TA.

Mol Cancer Res. 2007 Dec;5(12):1296-303. doi: 10.1158/1541-7786.MCR-07-0232. Erratum in: Mol Cancer Res. 2008 Feb;6(2):340.

19.

Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients.

Sample DC, Samadder NJ, Pappas LM, Boucher KM, Samowitz WS, Berry T, Westover M, Nathan D, Kanth P, Byrne KR, Burt RW, Neklason DW.

BMC Gastroenterol. 2018 Jul 16;18(1):115. doi: 10.1186/s12876-018-0841-8.

20.

Effect of epidermal growth factor administration on intestinal cell proliferation, crypt fission and polyp formation in multiple intestinal neoplasia (Min) mice.

Bashir O, Fitzgerald AJ, Berlanga-Acosta J, Playford RJ, Goodlad RA.

Clin Sci (Lond). 2003 Sep;105(3):323-30.

PMID:
12749762

Supplemental Content

Support Center